Answer
Onivyde pegylated liposomal has been associated with thromboembolic events including pulmonary embolism, venous thrombosis and arterial thromboembolism.
Sources for this answer
- ONIVYDE pegylated liposomal 4.3 mg/ml concentrate for dispersion for infusionServier Laboratories Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 13Document updated
Sources checked